|
WO2019202479A1
|
|
Method to perform diagnosis and prognosis of melanoma and kit
|
|
WO2019116412A1
|
|
Method for in vitro diagnosis of amyotrophic lateral sclerosis
|
|
WO2019007925A1
|
|
Method for the multi-parametric analysis of programmed cell death by flow cytometry
|
|
EP3463476A2
|
|
Buthionine sulfoximine and a metallodrug for the treatment of cancer, hiv or a rheumatic disease
|
|
WO2019122981A1
|
|
INHIBITOR COMPOUNDS OF THE HUMAN GTPase Rac1 FOR USE IN THE TREATMENT OF MALARIA
|
|
EP3559256A1
|
|
Method for determining attention deficit hyperactivity
|
|
WO2018092171A1
|
|
Conjugative vectors selectable by fructooligosaccharides
|
|
US2017283805A1
|
|
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration
|
|
IT201600101794A1
|
|
Nucleotide sequence expressing an exosome anchoring protein for use as a vaccine.
|
|
US2019016686A1
|
|
Salts of compounds having a benzimidazolic structure, uses and process for the preparation thereof
|
|
IT201600076743A1
|
|
NEW USE OF CNF1
|
|
EP2883052A1
|
|
Biomarkers
|
|
EP2822595A1
|
|
Sphingosine-1 -phosphate receptors modulators for improving vaccine immunization
|
|
EP2758423A2
|
|
Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease
|
|
EP2304428A1
|
|
System for environment diagnostic and monitoring and self-control of food chain
|
